Guided Therapeutics Receives ISO Certification
Paves the way for CE Mark for Cervical Pre-cancer Scanner
Press Release Source: Guided Therapeutics, Inc. On Thursday January 27, 2011, 9:33 am EST
NORCROSS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP), developer of the LightTouch™, a rapid, non-invasive and painless test for the early detection of cervical pre-cancer currently under review at the FDA, today announced that it was awarded ISO 13485:2003 registration certification.
“Receiving this certification is a very important milestone for the company and its shareholders and paves the way for the future sale of our products in the European Union and other countries that recognize the importance of the CE mark,” said Mark L. Faupel, CEO and president of Guided Therapeutics, Inc. “We believe that the LightTouch has significant market potential outside the U.S. and this certification demonstrates that the company has created a high-quality and world-class organization for the design, manufacture and distribution of our products internationally. I congratulate all the members of the Guided Therapeutics team that put so much effort into this successful process.”
The certificate of registration was issued by Intertek Testing Services NA Ltd. Intertek is a leading provider of quality and safety solutions, serving a wide range of industries around the world. For more information, visit www.intertek.com.
The International Organization for Standardization (ISO) is a non-governmental organization. Established in 1947, ISO currently works with the national standards institutes of over 140 countries to establish international standards. These standards are established to meet the needs of business and society. For more information, visit iso.org.
To view the certificate, visit guidedinc.com |
